Placenta and Reproductive Medicine (PRM) has been launched in July 2022.

PRM is a multidisciplinary journal covering a wide range of research including molecular biology, cell biology, pharmacology, systems biology, bioinformatics, clinical medicine biomedical engineering research, and translational research of placenta that are relevant to clinical practice. In addition, there will be a section of "placental diseases" that includes clinical issues resulting from placental dysfunction, such as intrauterine growth restriction, preeclampsia, preterm birth, etc. The specific topics of the journal will include but are not limited to Placenta-Related Pregnancy Complications, Placental and Reproductive Endocrinology, Placental and Reproductive Immunology, Placenta and Child Health, Placental Pathology, Assisted Reproductive Technology, Reproductive Disease, Placental Development, Placental Omics, Biomedical Engineering, Translational Research, Male Reproduction, Fetal Membrane, Animal Model, Biomarker, etc.

The journal welcomes submissions of clinical and basic research articles, reviews, case reports, case studies, case series, commentary, letters to the editor, mini-reviews, opinions, short communication, perspectives, editorials, etc. Articles published by PRM can be accessed and downloaded at: https://www.hksmp.com/journals/prm.

The Editors-in-Chief are Professor Chong Qiao and Professor Nanbert Zhong. The Editorial Board of PRM is consisted of outstanding experts all over the world.